ArticleNature medicine2026

Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.

Edgar Gonzalez-Kozlova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.